SALT LAKE CITY, July 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the ...
LifeVantage announces improved results from its MindBody GLP-1 System clinical trials, showing over 200% average increase in GLP-1. LifeVantage Corporation has revealed promising new results from its ...
Fiscal 2025 revenue guidance was reiterated at $235 million to $245 million, a 17% increase at the midpoint from prior guidance. Adjusted EBITDA guidance was raised to $21 million to $24 million, ...
Steven Fife, President and CEO, stated the company is "pleased with our fourth quarter results, including continued growth and improving margins." He reported that revenues grew approximately 13% year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results